Loading clinical trials...
Loading clinical trials...
A Phase III Randomised Study Comparing Concomitant Radiochemotherapy With Cisplatin and Docetaxel as Induction Versus Consolidation Treatment in Patients With Locally Advanced Unresectable Non-small Cell Lung Cancer.
Conditions
Interventions
Concomitant Radiochemotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel
Concomitant Chemoradiotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel
Locations
19
Belgium
Department of Pneumology RHMS Hôpital de la Madeleine
Ath, Belgium
Department of Pneumology Clinique Saint-Luc
Bouge, Belgium
Department of Pneumology CHR St Joseph-Warquignies
Boussu, Belgium
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet
Brussels, Belgium
Department of Pneumology Hospital Ixelles-Molière
Brussels, Belgium
Department of Pneumology CHU Charleroi
Charleroi, Belgium
Start Date
January 1, 2007
Primary Completion Date
December 1, 2014
Completion Date
February 1, 2015
Last Updated
February 12, 2015
NCT04585750
NCT07362459
NCT07050043
NCT04853342
NCT06899789
NCT06222489
Lead Sponsor
European Lung Cancer Working Party
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions